| Literature DB >> 35204585 |
Christopher Skusa1, Romy Skusa2, Moritz Wohlfarth1, Philipp Warnke2, Andreas Podbielski2, Kristina Bath1, Justus Groß3, Clemens Schafmayer3, Hagen Frickmann2,4, Marc-André Weber1, Andreas Hahn2, Felix G Meinel1.
Abstract
The aim of this investigation was to evaluate predictive CT imaging features and clinical parameters to distinguish infected from sterile fluid collections. Detection of infectious agents by advanced microbiological analysis was used as the reference standard. From April 2018 to October 2019, all patients undergoing CT-guided drainages were prospectively enrolled, if drainage material volume was at least 5 mL. Univariate analysis revealed attenuation (p = 0.001), entrapped gas (p < 0.001), fat stranding (p < 0.001), wall thickness (p < 0.001) and enhancement (p < 0.001) as imaging biomarkers and procalcitonin (p = 0.003) as clinical predictive parameters for infected fluid collections. On multivariate analysis, attenuation > 10 HU (p = 0.038), presence of entrapped gas (p = 0.027) and wall enhancement (p = 0.028) were independent parameters for distinguishing between infected and non-infected fluids. Gas entrapment had high specificity (93%) but low sensitivity (48%), while wall enhancement had high sensitivity (91%) but low specificity (50%). CT attenuation > 10 HU showed intermediate sensitivity (74%) and specificity (70%). Evaluation of the published proposed scoring systems did not improve diagnostic accuracy over independent predictors in our study. In conclusion, this prospective study confirmed that CT attenuation > 10 HU, entrapped gas and wall enhancement are the key imaging features to distinguish infected from sterile fluid collections on CT.Entities:
Keywords: CT; abscess; attenuation; drainage; gas entrapment; infection; wall enhancement
Year: 2022 PMID: 35204585 PMCID: PMC8870876 DOI: 10.3390/diagnostics12020493
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1An 83-year-old woman with chambered pleural effusion (→) and CT attenuation of 8 HU. After percutaneous drainage, no pathogen was detected by microbiological approach.
Figure 2A 63-year-old man with presacral abscess (*), demonstrating gas entrapment (→), wall enhancement (>), fat stranding and CT attenuation of 29 HU. Microbiology after percutaneous drainage confirmed infection.
Demographic data of patients with fluid collection.
| Characteristics | |
|---|---|
| No. of CT-guided drainages performed (n1) | 100 |
| No. of patients (n2) | 87 |
| Age, years (±SD) | 63 (±16) |
| Sex, male/female (n2 = 78) | 59/28 |
| Localization of fluid collection (n1 = 100) | |
| Thorax | 21 |
| Abdomen | 69 |
| Musculoskeletal | 10 |
| Underlying primary disease (n1 = 100) | |
| Carcinoma | 38 |
| Infection or inflammation | 41 |
| Vascular | 13 |
| Other | 8 |
| Referring unit (n1 = 100) | |
| General and visceral surgery | 43 |
| Intensive care unit | 23 |
| Internal medicine | 20 |
| Urology | 5 |
| Other surgical departments | 8 |
| Other departments | 1 |
CT imaging findings, laboratory results, and clinical data of patients with fluid collection.
| Imaging Parameter | All Lesions (n = 100) | Infected Fluid Collection (n = 73) | Sterile Fluid Collection (n = 27) | |
|---|---|---|---|---|
| Attenuation, HU | Median (IQR) | 14 (13) | 5 (14) |
|
| Entrapped gas | Existent | 35 | 2 |
|
| None | 38 | 25 | ||
| Wall thickness, mm | Median (IQR) | 2.6 (1.55) | 0 (2.2) |
|
| Wall enhancement | Existent | 60 | 10 |
|
| Strong | 30 | 5 | ||
| Slight | 30 | 5 | ||
| None | 6 | 10 | ||
| Scan without contrast | 7 | 7 | ||
| Fat stranding (without thorax, n = 79) | Existent | 61 | 7 |
|
| None | 7 | 4 | ||
| Clinical and laboratory parameters | ||||
| CRP, mg/L (n = 94) | Median (IQR) | 161 (145) | 107 (187) | 0.096 |
| Leukocytes, 103/µL (n = 99) | Median (IQR) | 12.5 (7.7) | 11.7 (7.9) | 0.356 |
| Procalcitonin, ng/mL (n = 25) | Median (IQR) | 3.0 (28.0) | 0.4 (0.3) |
|
| Diabetes (n = 27) | 20 | 7 | 1 | |
| Immunosuppressive drugs (n = 15) | 13 | 2 | 0.23 | |
| Chemotherapeutics (n = 14) | 10 | 4 | 1 | |
| Previous antibiotic therapy (n = 95) | 0.801 | |||
| yes | 50 | 18 | ||
| no | 19 | 8 | ||
| Previous operation (n = 95) | 49 | 18 | 1 |
HU—Hounsfield units; CRP—C-reactive protein.
Test characteristics for parameters to identify microorganism-containing fluid collections.
| Parameter | Sens | Spec | NPV | PPV | AUC |
|---|---|---|---|---|---|
| Fat stranding present (n = 100) | 0.90 | 0.36 | 0.36 | 0.90 | 0.630 |
| Gas entrapment present (n = 100) | 0.48 | 0.93 | 0.40 | 0.95 | 0.703 |
| Wall thickness > 1 mm (n = 100) | 0.92 | 0.56 | 0.71 | 0.85 | 0.737 |
| Wall enhancement present (n = 86) | 0.91 | 0.50 | 0.63 | 0.86 | 0.705 |
| CT attenuation > 10 HU (n = 100) | 0.74 | 0.70 | 0.50 | 0.87 | 0.722 |
Sens—sensitivity; Spec—specificity; NPV—negative predictive value; PPV—positive predictive value; AUC—area under the curve.
Multivariate analysis.
| Parameter | β | OR | |
|---|---|---|---|
| Fat stranding | 0.906 | ||
| Gas entrapment | 1.830 | 0.027 | 6.234 |
| Wall enhancement | 1.582 | 0.028 | 4.865 |
| CT attenuation | 1.343 | 0.038 | 3.832 |
β—regression coefficient; OR—odds ratio.
Figure 3ROC curve for statistically significant parameters in multivariate regression analysis to identify microorganism-containing fluid collections applied to our cohort (n = 86).
Comparison of published scoring systems.
| Applied Score | Sens | Spec | NPV | PPV | AUC |
|---|---|---|---|---|---|
| Gnannt score | 0.84 | 0.47 | 0.44 | 0.86 | 0.656 |
| Radosa score | 0.70 | 0.59 | 0.35 | 0.86 | 0.643 |
Performance of published scoring systems in our patient cohort. Sens—sensitivity; Spec—specificity; NPV—negative predictive value; PPV—positive predictive value; AUC—area under the curve; CI—confidence interval.
Figure 4ROC curve for published scoring systems to identify microorganism-containing fluid collections, applied to our cohort.